1. A randomised, double‐blind, trial of the safety and efficacy of omarigliptin (a once‐weekly DPP‐4 inhibitor) in subjects with type 2 diabetes and renal impairment. Issue 6 (27th April 2017) Authors: Chacra, Antonio; Gantz, Ira; Mendizabal, Geraldine; Durlach, Lucila; O'Neill, Edward A.; Zimmer, Zachary; Suryawanshi, Shailaja; Engel, Samuel S.; Lai, Eseng Journal: International journal of clinical practice Issue: Volume 71:Issue 6(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017) Authors: Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S. Journal: Current medical research and opinion Issue: Volume 33:Number 10(2017) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control: 一项评估联合使用磺脲与二甲双胍治疗后血糖仍然控制不佳的2型糖尿病患者加用西格列汀治疗后的安全性与有效性的随机临床试验. (3rd February 2016) Authors: Moses, Robert G.; Round, Elizabeth; Shentu, Yue; Golm, Gregory T.; O'neill, Edward A.; Gantz, Ira; Engel, Samuel S.; Kaufman, Keith D.; Goldstein, Barry J. Journal: Journal of diabetes Issue: Volume 8:Number 5(2016:Sep.) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Issue 2 (22nd December 2021) Authors: Shankar, R. Ravi; Zeitler, Philip; Deeb, Asma; Jalaludin, Muhammad Yazid; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, K... Journal: Pediatric diabetes Issue: Volume 23:Issue 2(2022) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Issue 12 (16th August 2018) Authors: Scott, Russell; Morgan, Jerry; Zimmer, Zachary; Lam, Raymond L. H.; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Raji, Annaswamy Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 12(2018) Page Start: 2876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone. (3rd April 2017) Authors: Wang, Weiqing; Ning, Guang; Ma, Jianhua; Liu, Xiaomin; Zheng, Shaoxiong; Wu, Fan; Xu, Lei; O'Neill, Edward A.; Fujita, Kenji P.; Engel, Samuel S.; Kaufman, Keith D.; Shankar, R. Ravi Journal: Current medical research and opinion Issue: Volume 33:Number 4(2017) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution. (2nd April 2020) Authors: Weiner, Michael; Cummins, Jonathan; Raji, Annaswamy; Ofner, Susan; Iglay, Kristy; Teal, Evgenia; Li, Xiaochun; Engel, Samuel S.; Knapp, Kristina; Rajpathak, Swapnil; Baker, Jarod; Chatterjee, Arnaub K.; Radican, Larry Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes. (April 2018) Authors: Home, Philip; Shankar, R. Ravi; Gantz, Ira; Iredale, Carol; O'Neill, Edward A.; Jain, Lokesh; Pong, Annpey; Suryawanshi, Shailaja; Engel, Samuel S.; Kaufman, Keith D.; Lai, Eseng Journal: Diabetes research and clinical practice Issue: Volume 138(2018) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017) Authors: Handelsman, Yehuda; Lauring, Brett; Gantz, Ira; Iredale, Carol; O'Neill, Edward A.; Wei, Ziwen; Suryawanshi, Shailaja; Kaufman, Keith D.; Engel, Samuel S.; Lai, Eseng Journal: Current medical research and opinion Issue: Volume 33:Number 10(2017) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes. Issue 11 (6th July 2017) Authors: Gantz, Ira; Okamoto, Taro; Ito, Yuka; Okuyama, Kotoba; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Lai, Eseng Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 11(2017) Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗